Ken Griffin Organon & Co. Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Organon & Co. stock. As of the latest transaction made, Citadel Advisors LLC holds 227,300 shares of OGN stock, worth $3.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

227,300

Previous 318,300 28.59%

Holding current value

$3.35 Million

Previous $6.59 Million 34.0%

% of portfolio

0.0%

Previous 0.0%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$18.65 - $23.03 $21.7 Million - $26.8 Million	1,162,145 Added 67.48%	2,884,453 $55.2 Million
Q2 2024 Aug 14, 2024	SELL	$17.45 - $21.96 $77.7 Million - $97.8 Million	-4,454,702 Reduced 72.12%	1,722,308 $35.7 Million
Q1 2024 May 15, 2024	BUY	$13.78 - $18.8 $27.1 Million - $37 Million	1,966,914 Added 46.72%	6,177,010 $116 Million
Q4 2023 Feb 14, 2024	BUY	$10.95 - $17.32 $25.7 Million - $40.7 Million	2,347,869 Added 126.08%	4,210,096 $60.7 Million
Q3 2023 Nov 14, 2023	BUY	$16.59 - $23.77 $15.3 Million - $21.9 Million	920,423 Added 97.73%	1,862,227 $32.3 Million
Q2 2023 Aug 14, 2023	BUY	$19.27 - $24.63 $9.84 Million - $12.6 Million	510,668 Added 118.45%	941,804 $19.6 Million
Q1 2023 May 15, 2023	SELL	$21.42 - $32.08 $20.4 Million - $30.5 Million	-950,688 Reduced 68.8%	431,136 $10.1 Million
Q4 2022 Feb 14, 2023	BUY	$23.31 - $28.61 $8.45 Million - $10.4 Million	362,347 Added 35.54%	1,381,824 $38.6 Million
Q3 2022 Nov 14, 2022	BUY	$23.4 - $34.25 $23.4 Million - $34.2 Million	998,554 Added 4772.52%	1,019,477 $23.9 Million

Others Institutions Holding OGN

# of Institutions

791

Shares Held

193M

Call Options Held

1.71M

Put Options Held

865K

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account